Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review.
Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Raso FM, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators.
Barbieri M, et al. Among authors: mani ly.
Pharmacol Res. 2024 Mar 16;203:107146. doi: 10.1016/j.phrs.2024.107146. Online ahead of print.
Pharmacol Res. 2024.
PMID: 38493928
Free article.
Review.